DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Sharma T, Reed C, Aasen I et al.
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Schizophr Res 2006;
85: 73-83
We do not assume any responsibility for the contents of the web pages of other providers.